Propranolol as a novel, effective spermicide: Preliminary findings
Author
dc.contributor.author
Zipper,
Author
dc.contributor.author
Wheeler,
Author
dc.contributor.author
Potts,
Author
dc.contributor.author
Rivera, Sebastián
Admission date
dc.date.accessioned
2019-01-29T14:20:43Z
Available date
dc.date.available
2019-01-29T14:20:43Z
Publication date
dc.date.issued
1983
Cita de ítem
dc.identifier.citation
British Medical Journal, Volumen 287, Issue 6401, 2018, Pages 1245-1246
Identifier
dc.identifier.issn
09598146
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/160488
Abstract
dc.description.abstract
The efficacy and tolerability of 80 mg propranolol tablets as a vaginal contraceptive were studied in 198 fertile women for 11 months. The calculated one year life table pregnancy rate was 3.4/100 women and the Pearl index was 3.9/100 women years. No major adverse effects were encountered. The findings suggested that propranolol is an effective vaginal contraceptive whose failure rate compares favourably with that of other methods of contraception. Further study of propranolol and similar compounds is warranted.